CAS No. |
2765065-09-4 |
|---|---|
英文名称 |
LP11 |
别名 |
GLP-1R agonist 19 |
标准英文名 |
(8S,14S,17S,20S,23S,26S)-8-((1H-tetrazol-5-yl)methyl)-26-(((S)-3-(4'-(4-(4-(25-amino-2,5,8,11,14,17,20,23-octaoxapentacosyl)-1H-1,2,3-triazol-1-yl)butoxy)-2'-ethyl-[1,1'-biphenyl]-4-yl)-1-(((S)-1-amino-5-(3,5-dimethylphenyl)-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)carbamoyl)-17-(2-fluorobenzyl)-14,20-bis((R)-1-hydroxyethyl)-23-(hydroxymethyl)-1-(1H-imidazol-5-yl)-5,5,17-trimethyl-4,6,9,12,15,18,21,24-octaoxo-3,7,10,13,16,19,22,25-octaazaoctacosan-28-oic acid |
分子式 |
C94H136FN21O25 |
分子量 |
1979.24 |
精确分子量 |
1978.00 |
SMILES |
CCC1=CC(OCCCCN2C=C(COCCOCCOCCOCCOCCOCCOCCOCCN)N=N2)=CC=C1C1=CC=C(C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@](C)(CC2=CC=CC=C2F)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC2=NN=NN2)NC(=O)C(C)(C)C(=O)NCCC2=CN=CN2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCC2=CC(C)=CC(C)=C2)C(N)=O)C=C1 |
标准SMILES |
CC(C)(C(=O)NCCC1=CN=CN1)C(=O)N[C@@H](CC1NN=NN=1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@](C)(CC1=CC=CC=C1F)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1C=CC(=CC=1)C1=CC=C(C=C1CC)OCCCCN1C=C(COCCOCCOCCOCCOCCOCCOCCOCCN)N=N1)C(=O)N[C@@H](CCCC1C=C(C)C=C(C)C=1)C(N)=O |
用途 |
GLP-1R agonist 19 is a potent and selective agonist of the glucagon-like peptide-1 receptor (GLP-1R), used for its therapeutic potential in metabolic disorders such as type 2 diabetes and obesity. |
InChIKey |
URZJTJFWQSLBQI-CQELQHIGSA-N |
|
|
评论 |
|---|